CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
48 hedge funds and large institutions have $19.3M invested in Carisma Therapeutics in 2019 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.76% less ownership
Funds ownership: 1.97% → 1.21% (-0.76%)
55% less capital invested
Capital invested by funds: $43.3M → $19.3M (-$24M)
Holders
48
Holding in Top 10
1
Calls
$37K
Puts
–
Top Buyers
| 1 | +$859K | |
| 2 | +$258K | |
| 3 | +$258K | |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$129K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$103K |
Top Sellers
| 1 | -$10.7M | |
| 2 | -$4.73M | |
| 3 | -$1.35M | |
| 4 |
Millennium Management
New York
|
-$1.09M |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
-$492K |